1. Home
  2. CSPI vs EPRX Comparison

CSPI vs EPRX Comparison

Compare CSPI & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSPI
  • EPRX
  • Stock Information
  • Founded
  • CSPI 1968
  • EPRX 2011
  • Country
  • CSPI United States
  • EPRX Canada
  • Employees
  • CSPI N/A
  • EPRX N/A
  • Industry
  • CSPI EDP Services
  • EPRX
  • Sector
  • CSPI Technology
  • EPRX
  • Exchange
  • CSPI Nasdaq
  • EPRX NYSE
  • Market Cap
  • CSPI 127.2M
  • EPRX 111.1M
  • IPO Year
  • CSPI 1987
  • EPRX N/A
  • Fundamental
  • Price
  • CSPI $17.74
  • EPRX $3.18
  • Analyst Decision
  • CSPI
  • EPRX Strong Buy
  • Analyst Count
  • CSPI 0
  • EPRX 1
  • Target Price
  • CSPI N/A
  • EPRX $9.00
  • AVG Volume (30 Days)
  • CSPI 42.4K
  • EPRX 24.6K
  • Earning Date
  • CSPI 02-12-2025
  • EPRX 02-07-2025
  • Dividend Yield
  • CSPI 0.66%
  • EPRX N/A
  • EPS Growth
  • CSPI N/A
  • EPRX N/A
  • EPS
  • CSPI 0.27
  • EPRX N/A
  • Revenue
  • CSPI $57,512,000.00
  • EPRX N/A
  • Revenue This Year
  • CSPI N/A
  • EPRX N/A
  • Revenue Next Year
  • CSPI N/A
  • EPRX N/A
  • P/E Ratio
  • CSPI $64.11
  • EPRX N/A
  • Revenue Growth
  • CSPI N/A
  • EPRX N/A
  • 52 Week Low
  • CSPI $9.07
  • EPRX $2.20
  • 52 Week High
  • CSPI $29.93
  • EPRX $4.08
  • Technical
  • Relative Strength Index (RSI)
  • CSPI 55.74
  • EPRX N/A
  • Support Level
  • CSPI $16.41
  • EPRX N/A
  • Resistance Level
  • CSPI $18.37
  • EPRX N/A
  • Average True Range (ATR)
  • CSPI 1.71
  • EPRX 0.00
  • MACD
  • CSPI -0.04
  • EPRX 0.00
  • Stochastic Oscillator
  • CSPI 38.03
  • EPRX 0.00

About CSPI CSP Inc.

CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.

About EPRX EUPRAXIA PHARMACEUTICALS INC

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.

Share on Social Networks: